Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features

18 Feb 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Neurological disorders and treatments
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32169356
DOI: 10.1016/j.neurobiolaging.2020.02.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical featuresPMID 32169356Read ↗

Parkinson's disease--the continuing search for biomarkers.Semantic proximity Read ↗

Cerebrospinal fluid biomarker for Parkinson's disease: An overviewSemantic proximity Read ↗

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomicsSemantic proximity Read ↗

Differences in Blood and Cerebrospinal Fluid Between Parkinson’s Disease and Related DiseasesSemantic proximity Read ↗

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approachSemantic proximity Read ↗

Changes in the cerebrospinal fluid proteome precede and stratify the course of Parkinson’s DiseaseSemantic proximity Read ↗

Diagnostic biomarkers for Parkinson's disease at a glance: where are we?Semantic proximity Read ↗

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s diseaseSemantic proximity Read ↗

Extracellular vesicles from bodily fluids for the accurate diagnosis of Parkinson’s disease and related disorders: A systematic review and meta-analysisSemantic proximity Read ↗

Proteomics in Human Parkinson’s Disease: Present Scenario and Future DirectionsSemantic proximity Read ↗

Biomarkers of Parkinson's Disease: Screening Vital Signs and Routine Blood TestsSemantic proximity Read ↗

From phenotype to biology: a multi-modal roadmap of biofluid, tissue, imaging, and digital biomarkers in Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.